From Medscape Cardiology

Medscape Medical News from the:

American Heart Association (AHA) 2011 Scientific Sessions

November 12 - 16, 2011; Orlando, Florida

This coverage is not sanctioned by, nor a part of, the American Heart Association.

Meeting Highlights at a Glance

Top News From AHA 2011: Slideshow
Among the AHA 2011 highlights: AIM-HIGH was stopped early due to increase in ischemic stroke in the niacin group vs placebo, and SATURN results showed that high-dose statin therapy resulted in significant regression of coronary atherosclerosis.

Conference News

Daily Coverage

Melissa Walton-Shirley, MD, reports daily from the American Heart Association (AHA) 2011 Scientific Sessions in Orlando, Fla. She highlights the critical findings from this important meeting that could have major effects on the treatment of cardiology patients.

Expert Commentary

Latest on LVADs: What All Docs Need to Know
Ileana L. Piña, MD, MPH;
James K. Kirklin, MD

Digoxin: Watch for Toxicity in Your Afib Patients!
Ileana L. Piña, MD, MPH;
Paul J. Hauptman, MD

 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.